CLINICAL_TRIALS
trial_result
· 2015-09-01
Clinical Trial Update: Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis [Phase 1]
Summary
A Phase 1 multiple-dose study of UCB4940 in subjects with psoriatic arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Celltech | Conditions: Psoriatic Arthritis | Phase 1 | Status: COMPLETED